- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lapatinib and Paclitaxel
Total 272146 results
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
Institute of Cancer Research, United KingdomGlaxoSmithKlineCompletedBreast CancerUnited Kingdom
-
Elevar TherapeuticsCompletedAdenoid Cystic CarcinomaUnited States, Korea, Republic of
-
Shanghai Jiao Tong University Affiliated Sixth...UnknownSoft Tissue Sarcoma
-
GlaxoSmithKlineCompletedNeoplasms, Head and NeckSpain, Peru, France, United States, Netherlands, India, Hungary, United Kingdom, Canada
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedAdenocarcinomaNetherlands, United States, Peru
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
Shoucheng MaUnknownColorectal NeoplasmsChina
-
Beijing HospitalChinese Society of Clinical OncologyRecruiting
-
Wuhan Union Hospital, ChinaWithdrawnColorectal Cancer | Chemotherapy | Angiogenesis
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastSpain, Canada, United States, Australia, Austria, Italy, Japan, Poland, Sweden, France, Germany, Switzerland, Taiwan, United Kingdom, Belgium, Greece, India
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Netherlands
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
GlaxoSmithKlineCompletedMetastatic Cervical Cancer | Neoplasms, Uterine CervixUnited States, Germany, Spain, Thailand, Belgium, Italy, Argentina, Canada, Ireland, India, France, Estonia, Mexico
-
Tianjin Medical University Cancer Institute and...Unknown
-
RemeGen Co., Ltd.RecruitingGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
Istituto Clinico HumanitasCompleted
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHead and Neck Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
University of Wisconsin, MadisonGlaxoSmithKlineCompletedMetastatic Colorectal CancerUnited States
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal Cancer by AJCC V8 StageChina
-
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
-
German Breast GroupAGO Study GroupCompleted
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Ruijin HospitalActive, not recruitingGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
National Cancer Institute (NCI)CompletedMetastatic Squamous Neck Cancer With Occult Primary | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompleted
-
SCRI Development Innovations, LLCSanofi; GlaxoSmithKline; NovartisTerminatedMetastatic Breast Cancer With Intracranial MetastasesUnited States
-
Ruijin HospitalRecruiting
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastCanada, Netherlands, United States, Spain, Korea, Republic of
-
RenJi HospitalActive, not recruiting
-
Peking Union Medical College HospitalCompletedApatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer (ACABC)Cholangiocarcinoma | Hepatobiliary Neoplasm | Biliary Tract Cancer | BiomarkerChina
-
Peking Union Medical College HospitalCompleted
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
GlaxoSmithKlineCompleted
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
Jiangsu HengRui Medicine Co., Ltd.The Affiliated Hospital of the Chinese Academy of Military Medical SciencesUnknownRecurrent and Metastatic Gastric CancerChina
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage IV Prostate CancerCanada
-
Cancer Institute and Hospital, Chinese Academy...Unknown